{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:49:16Z","timestamp":1793317756039,"version":"4.5.0"},"reference-count":70,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The association of bariatric surgery and newer glucagon-like peptide-1 receptor agonists (GLP-1RAs; semaglutide and tirzepatide) with body composition still lack evidence from clinical settings.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine temporal changes in fat-free mass (FFM), fat mass (FM), and FFM to FM ratio after bariatric surgery or GLP-1RA treatment over 24 months.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective cohort study used electronic health records from Vanderbilt University Medical Center of 1257 patients aged 18 to 65 years who underwent first-time bariatric surgery from November 21, 2017, to July 21, 2022, without GLP-1RA treatment from 1 year before to 2 years after surgery, and 1809 nonsurgical patients who started semaglutide or tirzepatide between November 12, 2018, and December 6, 2023, with 2 or more prescriptions or 5% or more weight loss. All patients had 2 or more bioelectrical impedance analysis measures and no history of end-stage kidney disease or congestive heart failure.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Bariatric surgery or GLP-1RA (semaglutide or tirzepatide) treatment.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Relative changes in FFM, FM, and FFM to FM ratio over 24 months, controlling for age, sex, race, baseline body mass index (BMI), diabetes history, treatment year, time (restricted cubic splines), and time spline-by-treatment interaction.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study comprised 3066 patients: 1257 in the surgery group (mean [SD] age, 43.4 [10.3] years; mean [SD] baseline BMI, 46.8 [7.1]; 1033 women [82.2%]) and 1809 in the GLP-1RA group (mean [SD] age, 45.4 [11.3] years; mean [SD] baseline BMI, 41.0 [7.9]; 1457 women [80.5%]). Adjusted mean relative FM reductions in the surgery group were 42.4% (95% CI, 41.5%-43.2%) at 6 months, 49.7% (95% CI, 48.8%-50.6%) at 12 months, and 49.7% (95% CI, 47.8%-51.5%) at 24 months; reductions in the GLP-1RA group were 10.3% (95% CI, 9.5%-11.0%) at 6 months, 17.3% (95% CI, 16.5%-18.1%) at 12 months, and 18.0% (95% CI, 16.4%-19.7%) at 12 months. Adjusted mean relative FFM reductions in the surgery group were 7.8% (95% CI, 7.2%-8.4%) at 6 months, 10.6% (95% CI, 10.0%-11.2%) at 12 months, and 11.7% (95% CI, 10.4%-12.9%) at 24 months; reductions in the GLP-1RA group were 1.8% (95% CI, 1.3%-2.4%) at 6 months, 3.0% (95% CI, 2.4%-3.5%) at 12 months, and 3.3% (95% CI, 2.1%-4.4%) at 24 months. FFM to FM ratios increased significantly in both groups, with surgical patients maintaining a higher ratio throughout: the FFM to FM ratios in the surgery group were 1.8 (95% CI, 1.8-1.8) at 6 months, 2.1 (95% CI, 2.1-2.1) at 12 months, and 2.0 (95% CI, 2.0-2.1) at 24 months; the FFM to FM ratios in the GLP-1RA group were 1.4 (95% CI, 1.4-1.4) at 6 months, 1.5 (95% CI, 1.4-1.5) at 12 months, and 1.5 (95% CI, 1.5-1.6) at 24 months. Similar trends were observed in stratified analyses by sex, race, baseline BMI, baseline diabetes status, and GLP-1RA treatment duration, although men showed better FFM preservation than women, especially after GLP-1RA treatment.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this single-center cohort study, both bariatric surgery and semaglutide or tirzepatide treatment were associated with substantial FM loss, moderate FFM loss, and improved FFM to FM ratio. These findings provide evidence to guide interventions aimed at preserving FFM while promoting fat loss.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.53323","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:30:33Z","timestamp":1767976233000},"page":"e2553323","source":"Crossref","is-referenced-by-count":15,"title":["Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists"],"prefix":"10.1001","volume":"9","author":[{"given":"Zicheng","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Computer Science, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D.","family":"Lowery","sequence":"additional","affiliation":[{"name":"Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren Lee","family":"Shaffer","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Computer Science, Vanderbilt University, Nashville, Tennessee"},{"name":"Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinn S.","family":"Wells","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Flynn","sequence":"additional","affiliation":[{"name":"Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Spann","sequence":"additional","affiliation":[{"name":"Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitanjali","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee"},{"name":"Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Samuels","sequence":"additional","affiliation":[{"name":"Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danxia","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"14","key":"zoi251419r1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults, 1999-2000.","volume":"288","author":"Flegal","year":"2002","journal-title":"JAMA"},{"issue":"25","key":"zoi251419r3","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. state-level prevalence of adult obesity and severe obesity.","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi251419r4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","article-title":"Why does obesity cause diabetes?","volume":"34","author":"Klein","year":"2022","journal-title":"Cell Metab"},{"issue":"1","key":"zoi251419r5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.21037\/gs.2019.12.03","article-title":"Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery.","volume":"9","author":"Shariq","year":"2020","journal-title":"Gland Surg"},{"issue":"21","key":"zoi251419r6","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association.","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"zoi251419r7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.alit.2023.08.007","article-title":"Impact of obesity in asthma: possible future therapies.","volume":"73","author":"Tashiro","year":"2024","journal-title":"Allergol Int"},{"issue":"2","key":"zoi251419r8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cancers15020485","article-title":"Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management.","volume":"15","author":"Pati","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"zoi251419r9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7861\/clinmedicine.19-3-205","article-title":"Current treatments for obesity.","volume":"19","author":"Ruban","year":"2019","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"zoi251419r10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jamasurg.2024.7052","article-title":"Long-term outcomes of laparoscopic Roux-en-Y gastric bypass vs laparoscopic sleeve gastrectomy for obesity: the SM-BOSS randomized clinical trial.","volume":"160","author":"Kraljevic","year":"2025","journal-title":"JAMA Surg"},{"issue":"10","key":"zoi251419r11","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial.","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat Med"},{"issue":"10402","key":"zoi251419r12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.","volume":"402","author":"Garvey","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"zoi251419r13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity.","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"zoi251419r14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejim.2023.09.002","article-title":"Body mass index (BMI): still be used?","volume":"117","author":"Muscogiuri","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"3","key":"zoi251419r15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/ajcn\/nqaa339","article-title":"Relation of body fat mass and fat-free mass to total mortality: results from 7 prospective cohort studies.","volume":"113","author":"Sedlmeier","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"zoi251419r16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007505","article-title":"Association between adiposity and lean mass with long-term cardiovascular events in patients with coronary artery disease: no paradox.","volume":"7","author":"Medina-Inojosa","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"zoi251419r17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.hrtlng.2022.07.006","article-title":"Fat mass to fat-free mass ratio and its associations with clinical characteristics in asthma.","volume":"56","author":"Rugila","year":"2022","journal-title":"Heart Lung"},{"issue":"1","key":"zoi251419r18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12986-021-00551-6","article-title":"Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals.","volume":"18","author":"Dai","year":"2021","journal-title":"Nutr Metab (Lond)"},{"key":"zoi251419r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2024.116151","article-title":"Weight loss outcomes and associated factors after metabolic bariatric surgery: analysis of routine clinical data in Scotland.","volume":"241","author":"Leyaro","year":"2025","journal-title":"Am J Surg"},{"issue":"2","key":"zoi251419r20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/oby.23622","article-title":"Real-world weight-loss effectiveness of glucagon-like peptide-1 agonists among patients with type 2 diabetes: a retrospective cohort study.","volume":"31","author":"White","year":"2023","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"zoi251419r21","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/oby.23563","article-title":"Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: a systematic review and meta-analysis.","volume":"30","author":"Sarma","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"zoi251419r22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamasurg.2025.3590","article-title":"Obesity treatment with bariatric surgery vs GLP-1 receptor agonists.","volume":"160","author":"Barrett","year":"2025","journal-title":"JAMA Surg"},{"issue":"6","key":"zoi251419r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.15392","article-title":"Bariatric metabolic surgery vs glucagon-like peptide-1 receptor agonists and mortality.","volume":"7","author":"Dicker","year":"2024","journal-title":"JAMA Netw Open"},{"key":"zoi251419r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103213","article-title":"Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study.","volume":"83","author":"Wolff Sagy","year":"2025","journal-title":"EClinicalMedicine"},{"key":"zoi251419r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis.","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"key":"zoi251419r26","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2147\/DMSO.S443631","article-title":"Assessment of changes in body composition after 3 months of dulaglutide treatment.","volume":"17","author":"Chen","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"zoi251419r27","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae027","article-title":"Cardiometabolic improvements after metabolic surgery and related presurgery factors.","volume":"8","author":"Wang","year":"2024","journal-title":"J Endocr Soc"},{"issue":"9596","key":"zoi251419r28","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"zoi251419r29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1749-6632.2000.tb06441.x","article-title":"Bioelectrical impedance analysis: what does it measure?","volume":"904","author":"Schoeller","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"zoi251419r30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/1747-0080.12172","article-title":"Validity and reliability of bioelectrical impedance analysis to estimate body fat percentage against air displacement plethysmography and dual-energy X-ray absorptiometry.","volume":"73","author":"Von Hurst","year":"2016","journal-title":"Nutr Diet"},{"issue":"4","key":"zoi251419r31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.7326\/M22-3051","article-title":"Recommended and prevalent use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in a national population-based sample.","volume":"176","author":"Tang","year":"2023","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi251419r32","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3224","article-title":"Metabolic and bariatric surgery for pediatric patients with severe obesity.","volume":"144","author":"Bolling","year":"2019","journal-title":"Pediatrics"},{"issue":"10","key":"zoi251419r33","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1038\/s41591-025-03893-3","article-title":"Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity.","volume":"31","author":"Gasoyan","year":"2025","journal-title":"Nat Med"},{"key":"zoi251419r34","doi-asserted-by":"publisher","author":"Deanfield","journal-title":"Lancet","DOI":"10.1016\/S0140-6736(25)01375-3"},{"issue":"17-18","key":"zoi251419r35","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1177\/1535370218818161","article-title":"Body composition and mortality in the general population: a review of epidemiologic studies.","volume":"243","author":"Lee","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"issue":"10","key":"zoi251419r36","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41366-020-0613-8","article-title":"Levels and changes in body mass index decomposed into fat and fat-free mass index: relation to long-term all-cause mortality in the general population.","volume":"44","author":"S\u00f8rensen","year":"2020","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"zoi251419r37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.ijo.0801082","article-title":"Mortality associated with body fat, fat-free mass and body mass index among 60-year-old Swedish men\u2014a 22-year follow-up: the study of men born in 1913.","volume":"24","author":"Heitmann","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"zoi251419r38","doi-asserted-by":"publisher","first-page":"k2575","DOI":"10.1136\/bmj.k2575","article-title":"Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study.","volume":"362","author":"Lee","year":"2018","journal-title":"BMJ"},{"issue":"5","key":"zoi251419r39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","article-title":"Sarcopenic obesity in older adults: a clinical overview.","volume":"20","author":"Prado","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"zoi251419r40","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13534","article-title":"Deciphering the \u201cobesity paradox\u201d in the elderly: a systematic review and meta-analysis of sarcopenic obesity.","volume":"24","author":"Liu","year":"2023","journal-title":"Obes Rev"},{"issue":"1","key":"zoi251419r41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.14283\/jfa.2021.39","article-title":"Sarcopenic obesity and depression: a systematic review.","volume":"11","author":"Pilati","year":"2022","journal-title":"J Frailty Aging"},{"key":"zoi251419r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111704","article-title":"Prevalence and prognostic value of sarcopenic obesity in patients with cancer: a systematic review and meta-analysis.","volume":"101","author":"Gao","year":"2022","journal-title":"Nutrition"},{"issue":"1","key":"zoi251419r43","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13370","article-title":"The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: a systematic review and meta-analysis.","volume":"23","author":"Nuijten","year":"2022","journal-title":"Obes Rev"},{"issue":"1","key":"zoi251419r44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41366-024-01648-7","article-title":"Comparative effectiveness of metabolic and bariatric surgeries: a network meta-analysis.","volume":"49","author":"Malik","year":"2025","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"zoi251419r45","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1007\/s11695-021-05512-9","article-title":"How does fat mass change in the first year after bariatric surgery? a systemic review and meta-analysis.","volume":"31","author":"Haghighat","year":"2021","journal-title":"Obes Surg"},{"issue":"3","key":"zoi251419r46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00125-019-05065-8","article-title":"Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial.","volume":"63","author":"McCrimmon","year":"2020","journal-title":"Diabetologia"},{"issue":"11","key":"zoi251419r47","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity.","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi251419r48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity.","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"zoi251419r49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/1573399816666200705210006","article-title":"Effects of antidiabetic drugs on muscle mass in type 2 diabetes mellitus.","volume":"17","author":"Ida","year":"2021","journal-title":"Curr Diabetes Rev"},{"issue":"3","key":"zoi251419r50","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/dom.16162","article-title":"Weight loss and body composition after compounded semaglutide treatment in a real world setting.","volume":"27","author":"Chun","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"zoi251419r51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/dom.16364","article-title":"Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA\u2013based weight-loss therapies.","volume":"27","author":"Thomsen","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"zoi251419r53","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-70178-3","author":"Bredella","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"zoi251419r54","first-page":"499","article-title":"Gender differences in fat metabolism.","volume":"4","author":"Blaak","year":"2001","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"zoi251419r55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2010.04.056","article-title":"Metabolic impact of sex hormones on obesity.","volume":"1350","author":"Brown","year":"2010","journal-title":"Brain Res"},{"issue":"3","key":"zoi251419r56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1210\/me.2012-1271","article-title":"Neurokinin B causes acute GnRH secretion and repression of GnRH transcription in GT1-7 GnRH neurons.","volume":"27","author":"Glidewell-Kenney","year":"2013","journal-title":"Mol Endocrinol"},{"issue":"11","key":"zoi251419r57","doi-asserted-by":"publisher","first-page":"R1215","DOI":"10.1152\/ajpregu.00446.2012","article-title":"Sex differences in the physiology of eating.","volume":"305","author":"Asarian","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"zoi251419r58","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3945\/an.116.014506","article-title":"Preserving healthy muscle during weight loss.","volume":"8","author":"Cava","year":"2017","journal-title":"Adv Nutr"},{"issue":"1","key":"zoi251419r59","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1249\/MSS.0000000000001074","article-title":"Effects of weight loss on lean mass, strength, bone, and aerobic capacity.","volume":"49","author":"Weiss","year":"2017","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"zoi251419r60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-0030-1268008","article-title":"Resistance exercise and lipoproteins in postmenopausal women.","volume":"32","author":"Wooten","year":"2011","journal-title":"Int J Sports Med"},{"issue":"1","key":"zoi251419r61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41366-020-00708-y","article-title":"Examining differences between overweight women and men in 12-month weight loss study comparing healthy low-carbohydrate vs low-fat diets.","volume":"45","author":"Aronica","year":"2021","journal-title":"Int J Obes (Lond)"},{"key":"zoi251419r62","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1007\/s40279-014-0152-3","article-title":"A brief review of critical processes in exercise-induced muscular hypertrophy.","volume":"44","author":"Phillips","year":"2014","journal-title":"Sports Med"},{"key":"zoi251419r63","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2024.100533","article-title":"Glucagon-like peptide-1 receptor agonists for post\u2013bariatric surgery weight regain and insufficient weight loss: a systematic review.","volume":"46","author":"Pratama","year":"2024","journal-title":"Obes Med"},{"key":"zoi251419r64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nut.2017.09.005","article-title":"A comparison of three methods to assess body composition.","volume":"47","author":"Tewari","year":"2018","journal-title":"Nutrition"},{"issue":"4","key":"zoi251419r65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/metabo13040473","article-title":"Acute fluid intake impacts assessment of body composition via bioelectrical impedance analysis: a randomized, controlled crossover pilot trial.","volume":"13","author":"Schierbauer","year":"2023","journal-title":"Metabolites"},{"issue":"5","key":"zoi251419r66","first-page":"360","article-title":"How to best assess abdominal obesity.","volume":"21","author":"Fang","year":"2018","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"zoi251419r67","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002517","article-title":"Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK.","volume":"10","author":"Weiss","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"8","key":"zoi251419r68","doi-asserted-by":"publisher","first-page":"860","DOI":"10.18553\/jmcp.2024.23332","article-title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes.","volume":"30","author":"Gleason","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"zoi251419r69","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4997\/jrcpe.2020.409","article-title":"Retrospective studies\u2014utility and caveats.","volume":"50","author":"Talari","year":"2020","journal-title":"J R Coll Physicians Edinb"},{"issue":"4","key":"zoi251419r70","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/00325481.2022.2051366","article-title":"What is clinically relevant weight loss for your patients and how can it be achieved? a narrative review.","volume":"134","author":"Horn","year":"2022","journal-title":"Postgrad Med"},{"key":"zoi251419r2","doi-asserted-by":"crossref","DOI":"10.15620\/cdc\/159281","volume-title":"Obesity and Severe Obesity Prevalence in Adults: United States, August 2021\u2013August 2023","author":"Emmerich","year":"2024"},{"key":"zoi251419r52","volume-title":"Anthony\u2019s Textbook of Anatomy and Physiology\u2014E-Book","author":"Patton","year":"2018","edition":"21st ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2843518\/wang_2026_oi_251419_1767023535.23632.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:30:35Z","timestamp":1767976235000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2843518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.53323","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}